Literature DB >> 18275399

Public perceptions of communicating information about bowel cancer screening.

Chris Woodrow1, Eila Watson, Linda Rozmovits, Ronald Parker, Joan Austoker.   

Abstract

OBJECTIVES: The National Health Service has recently begun the introduction of a Bowel Cancer Screening Programme (BCSP), offering biennial screening to men and women aged 60-69 years. This study aimed to explore public perceptions regarding the communication of information designed to facilitate informed choice in relation to this new screening programme.
METHODS: Fourteen single sex focus groups were conducted in England with 86 individuals aged 60-69 years. Focus groups were conducted either with individuals who had participated in the pilot phase of the BCSP, or with members of the public living outside the pilot areas.
RESULTS: The majority of participants expressed positive attitudes towards bowel cancer screening, identifying items highlighting the benefits of the programme as important for others to know. Whilst some believed it was appropriate for information regarding the potentially negative aspects of the programme to be communicated at the outset, others expressed concerns about the generation of anxiety and potential for decreased participation. A number of participants questioned the concept of informed choice, arguing that once in place, a screening programme should be vigorously promoted.
CONCLUSIONS: There is some variation in the type of information favoured by those eligible for bowel cancer screening. This may present challenges for the provision of information aiming to facilitate informed choice in the BCSP. Flexible approaches to information provision that recognize the perceptions of patients may be required.

Entities:  

Mesh:

Year:  2008        PMID: 18275399      PMCID: PMC5060422          DOI: 10.1111/j.1369-7625.2007.00474.x

Source DB:  PubMed          Journal:  Health Expect        ISSN: 1369-6513            Impact factor:   3.377


  17 in total

Review 1.  Bridging the knowledge gap and communicating uncertainties for informed consent in cervical cytology screening; we need unbiased information and a culture change.

Authors:  C M Anderson; J Nottingham
Journal:  Cytopathology       Date:  1999-08       Impact factor: 2.073

Review 2.  Promoting informed decisions about cancer screening in communities and healthcare systems.

Authors:  Peter Briss; Barbara Rimer; Barbara Reilley; Ralph C Coates; Nancy C Lee; Patricia Mullen; Phaedra Corso; Angela B Hutchinson; Robert Hiatt; Jon Kerner; Prethibha George; Cornelia White; Nisha Gandhi; Mona Saraiya; Rosalind Breslow; George Isham; Steven M Teutsch; Alan R Hinman; Robert Lawrence
Journal:  Am J Prev Med       Date:  2004-01       Impact factor: 5.043

3.  Reconciling population benefits and women's individual autonomy in mammographic screening: in-depth interviews to explore women's views about 'informed choice'.

Authors:  Claire Davey; Victoria White; Melina Gattellari; Jeanette E Ward
Journal:  Aust N Z J Public Health       Date:  2005-02       Impact factor: 2.939

Review 4.  Informed choice for screening: implications for evaluation.

Authors:  Les Irwig; Kirsten McCaffery; Glenn Salkeld; Patrick Bossuyt
Journal:  BMJ       Date:  2006-05-13

5.  Aging and the desire for information and input in medical decisions: patient consumerism in medical encounters.

Authors:  A E Beisecker
Journal:  Gerontologist       Date:  1988-06

6.  How should we measure informed choice? The case of cancer screening.

Authors:  R G Jepson; J Hewison; A G H Thompson; D Weller
Journal:  J Med Ethics       Date:  2005-04       Impact factor: 2.903

Review 7.  Variability in patient preferences for participating in medical decision making: implication for the use of decision support tools.

Authors:  A Robinson; R Thomson
Journal:  Qual Health Care       Date:  2001-09

8.  Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message?

Authors:  Evelyn C Y Chan; Sally W Vernon; Frederick T O'Donnell; Chul Ahn; Anthony Greisinger; Donnie W Aga
Journal:  Am J Public Health       Date:  2003-05       Impact factor: 9.308

Review 9.  Patients' preferences for participation in clinical decision making: a review of published surveys.

Authors:  J Benbassat; D Pilpel; M Tidhar
Journal:  Behav Med       Date:  1998       Impact factor: 3.104

10.  Declining the offer of flexible sigmoidoscopy screening for bowel cancer: a qualitative investigation of the decision-making process.

Authors:  K McCaffery; J Borril; S Williamson; T Taylor; S Sutton; W Atkin; J Wardle
Journal:  Soc Sci Med       Date:  2001-09       Impact factor: 4.634

View more
  14 in total

1.  Reactions to a targeted intervention to increase fecal occult blood testing among average-risk adults waiting for screening colonoscopy.

Authors:  S Elizabeth McGregor; Paul Ritvo; Jill Tinmouth; Ashley Kornblum; Ronald Myers; Robert J Hilsden; Lawrence F Paszat; Linda Rabeneck
Journal:  Can J Gastroenterol       Date:  2011-05       Impact factor: 3.522

2.  Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.

Authors:  Cédric Rat; Corinne Pogu; Delphine Le Donné; Chloé Latour; Gaelle Bianco; France Nanin; Anne Cowppli-Bony; Aurélie Gaultier; Jean-Michel Nguyen
Journal:  JAMA       Date:  2017-09-05       Impact factor: 56.272

3.  Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial.

Authors:  P Hewitson; A M Ward; C Heneghan; S P Halloran; D Mant
Journal:  Br J Cancer       Date:  2011-08-09       Impact factor: 7.640

4.  The effect of a supplementary ('Gist-based') information leaflet on colorectal cancer knowledge and screening intention: a randomized controlled trial.

Authors:  Samuel G Smith; Rosalind Raine; Austin Obichere; Michael S Wolf; Jane Wardle; Christian von Wagner
Journal:  J Behav Med       Date:  2014-09-25

5.  Uptake in cancer screening programmes: a priority in cancer control.

Authors:  D P Weller; C Campbell
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

6.  Responses to procedural information about colorectal cancer screening using faecal occult blood testing: the role of consideration of future consequences.

Authors:  Christian von Wagner; Anna Good; Samuel G Smith; Jane Wardle
Journal:  Health Expect       Date:  2011-04-19       Impact factor: 3.377

7.  Communication about colorectal cancer screening in Britain: public preferences for an expert recommendation.

Authors:  J Waller; A Macedo; C von Wagner; A E Simon; C Jones; V Hammersley; D Weller; J Wardle; C Campbell
Journal:  Br J Cancer       Date:  2012-11-22       Impact factor: 7.640

8.  Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study.

Authors:  Jo Waller; Elaine Douglas; Katriina L Whitaker; Jane Wardle
Journal:  BMJ Open       Date:  2013-04-22       Impact factor: 2.692

9.  Knowledge and Informed Decision-Making about Population-Based Colorectal Cancer Screening Participation in Groups with Low and Adequate Health Literacy.

Authors:  M L Essink-Bot; E Dekker; D R M Timmermans; E Uiters; M P Fransen
Journal:  Gastroenterol Res Pract       Date:  2016-04-20       Impact factor: 2.260

10.  How do people interpret information about colorectal cancer screening: observations from a think-aloud study.

Authors:  Samuel G Smith; Gemma Vart; Michael S Wolf; Austin Obichere; Helen J Baker; Rosalind Raine; Jane Wardle; Christian von Wagner
Journal:  Health Expect       Date:  2013-08-05       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.